A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis (Q30316704)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Stephan Miehlke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Petr Hruz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Michael Vieth

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Christian Bussmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ulrike von Arnim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Monther Bajbouj

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Christoph Schlag

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ahmed Madisch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Christiane Fibbe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Henning Wittenburg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Hans Dieter Allescher

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Max Reinshagen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Stefan Schubert

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Michaela Müller

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Patrick Krummenerl

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Joris Arts

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ralph Mueller

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Karin Dilger

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Roland Greinwald

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Alex Straumann

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

19 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

390-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation

3 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

Prevalence of eosinophilic esophagitis in the United States

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

Therapeutic concepts in adult and paediatric eosinophilic oesophagitis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

Pediatric and adult eosinophilic esophagitis: similarities and differences

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

Eosinophilic esophagitis: updated consensus recommendations for children and adults

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4789829

Rapidly increasing incidence of eosinophilic esophagitis in a large cohort

3 June 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Active eosinophilic esophagitis is associated with impaired elimination of budesonide by cytochrome P450 3A enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2014-308815

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

21 January 2018

1 reference

12 December 2020

Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis

1 reference

12 December 2020

Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis

1 reference

12 December 2020

Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner

1 reference

12 December 2020

Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings

1 reference

12 December 2020

Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years

1 reference

12 December 2020

Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups

1 reference

12 December 2020

10.1136/GUTJNL-2014-308815

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25792708%20AND%20SRC:MED&resulttype=core&format=json